Full Year 2019 Basilea Pharmaceutica AG Earnings Call Transcript

Feb 18, 2020 / 03:00PM GMT
Operator

Ladies and gentlemen, welcome to Basilea Pharmaceutica's Full Year Results 2019 Conference Call and Live Webcast. I'm Alice, the Chorus Call operator. (Operator Instructions). And the conference is being recorded. The presentation will be followed by a Q&A session. (Operator Instructions).

The conference must not be recorded for publication or broadcast.

At this time, it's my pleasure to hand over to David Veitch, Chief Executive Officer. Please go ahead, sir.

David Veitch - Basilea Pharmaceutica AG - CEO

Thank you. Hello. This is David Veitch, CEO of Basilea. I would like to welcome you all to our conference call and webcast, reviewing our financial results and key achievements for 2019 and discussing our upcoming milestones and financial guidance for 2020. I would like also to mention that this call contains forward-looking statements.

Joining me on our call today are Adesh Kaul, our Chief Financial Officer; and Dr. Marc Engelhardt, our Chief Medical Officer.

This morning, we issued a press release and our financial

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot